Jeffrey S. Bland - Concepedia

Author

Jeffrey S. Bland

Abterra Biosciences (United States)

Also Known As

J Bland, J. BLAND, J. Bland, J. S. BLAND, J. S. Bland, J.S. Bland, Jeffrey Bland, Jeffrey S Bland, Jeffrey S. Bland

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Abterra Biosciences (United States)Psychogenics (United States)Metacomp Technologies (United States)Cornell University Scripps Research Institute

About

Jeffrey S. Bland is an author at Abterra Biosciences (United States) specializing in medicine, pharmacology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	934
2	Health Sciences	11	11	432
3	Biochemistry	6	6	236
4	Public Health	3	3	303
5	Natural Sciences	2	2	43

Jeffrey S. Bland

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Aging: The Reality: Biomarkers of Aging: From Primitive Organisms to Humans Robert N. Butler, Richard A. Sprott, Huber R. Warner, The Journals of Gerontology Series A AgingAnti-agingInformative BiomarkersBiogerontologyEpidemiology Of Aging	2004	205
Intestinal bitter taste receptor activation alters hormone secretion and imparts metabolic benefits Bernard P. Kok, Andrea Galmozzi, Nicole K. Littlejohn, Molecular Metabolism NutritionGastrointestinal PharmacologyGlucose ToleranceInsulin SignalingGastrointestinal Peptide Hormone	2018	121
Effect of a low glycemic index diet with soy protein and phytosterols on CVD risk factors in postmenopausal women Dan Lukaczer, J. Liska DeAnn, Robert H. Lerman, Nutrition Metabolic SyndromeNutritionNutritional EpidemiologySoy ProteinDiabetes	2006	86
A Pilot trial evaluating meta050, a proprietary combination of reduced iso-alpha acids, rosemary extract and oleanolic acid in patients with arthritis and fibromyalgia Daniel Lukaczer, Gary Darland, Matthew L. Tripp, Phytotherapy Research Pain MedicineFibromyalgiaInflammatory ArthritisProprietary CombinationInflammation	2005	64
Enhancement of a modified Mediterranean-style, low glycemic load diet with specific phytochemicals improves cardiometabolic risk factors in subjects with metabolic syndrome and hypercholesterolemia in a randomized trial Robert H. Lerman, Deanna M. Minich, Gary Darland, Nutrition & Metabolism	2008	57
Acid-alkaline balance: role in chronic disease and detoxification. Deanna M. Minich, Jeffrey S. Bland PubMed NutritionElectrolyte DisorderRedox BiologyAlkaline ReservesOxidative Stress	2007	51
Subjects with elevated LDL cholesterol and metabolic syndrome benefit from supplementation with soy protein, phytosterols, hops rho iso-alpha acids, and Acacia nilotica proanthocyanidins Robert H. Lerman, Deanna M. Minich, Gary Darland, Journal of clinical lipidology NutritionMetabolic SyndromeElevated Ldl CholesterolSoy ProteinLipid Nutrition	2009	43
Divergent effects of omega-6 and omega-3 fatty acids on mammary tumor development in C3H/Heston mice treated with DMBA Ewan Cameron, Jeffrey S. Bland, Richard Marcuson Nutrition Research Tumor BiologyOmega-3 Fatty AcidMedicineLipid NutritionImmunology	1989	42
META060 attenuates TNF-α-activated inflammation, endothelial–monocyte interactions, and matrix metalloproteinase-9 expression, and inhibits NF-κB and AP-1 in THP-1 monocytes Anuradha Desai, Gary Darland, Jeffrey S. Bland, Atherosclerosis InflammationCytokineThp-1 MonocytesMetalloproteinase-9 ExpressionImmune Regulation	2012	39
Clinical safety and efficacy of NG440: a novel combination of rho iso-alpha acids from hops, rosemary, and oleanolic acid for inflammatory conditionsThis article is one of a selection of papers published in this special issue (part 1 of 2) on the Safety and Efficacy of Natural Health Products. Deanna M. Minich, Jeffrey S. Bland, Jeffrey Katke, Canadian Journal of Physiology and Pharmacology	2007	39

Page 1